Related Experiment Video
Updated: Aug 7, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
A deep learning framework for radiotherapy dose prediction: from MLC motion to patient-specific dose perturbation
Liyuan Chen1, Hairui Yang2, Peng Jin3
1Chongqing University Cancer Hospital, No. 181, Hanyu Road, Shapingba District, Chongqing City, China, Chongqing, 400030, China.
Physics in Medicine and Biology
|August 5, 2026
Summary
This study introduces a new framework to predict radiotherapy dose errors from multi leaf collimator (MLC) uncertainties, improving patient-specific quality assurance (PSQA) for precision oncology.
Area of Science:
- Medical Physics
- Radiotherapy Technology
- Artificial Intelligence in Medicine
Background:
- Modern radiotherapy relies on multi leaf collimators (MLCs) for precise dose sculpting.
- Patient-specific quality assurance (PSQA) traditionally involves passive verification of treatment delivery.
- Accurate modeling of MLC-related delivery uncertainties is crucial for enhancing radiotherapy precision.
Purpose of the Study:
- To develop a physics-informed, interpretable framework for modeling MLC delivery uncertainties.
- To predict the dosimetric impact of MLC deviations on radiotherapy dose distributions.
- To transition PSQA from passive verification to proactive intervention by quantifying delivery uncertainty.
Main Methods:
- Analysis of trajectory log files from 1954 volumetric modulated arc therapy (VMAT) plans across two MLC designs.
- Modeling of control point level MLC and gantry deviations using motion metrics and a novel temporal latency parameter (ΔtMLC).
- Projection of deviations into 3D anatomy to create an MLC Position Deviation Texture (MPDT) and input into a dual pathway U-Net for dose prediction.
Main Results:
- MLC deviation patterns were design-specific with strong linear/quadratic relationships (average R² = 0.989).
- The MPDT-enhanced framework achieved superior dose prediction accuracy (SSIM = 0.996, PMAE = 0.39%) compared to conventional models.
- Improved consistency in gamma passing rate (GPR) was observed (ΔGPR = 2.40% vs. 3.92%), persisting in clinical testing.
Conclusions:
- The study presents a scalable paradigm for PSQA by integrating interpretable mechanical modeling with deep learning.
- This framework quantifies radiotherapy delivery uncertainty and traces dose deviations to their physical origins.
- The developed approach enables proactive intervention, enhancing the safety and efficacy of precision oncology treatments.